Cutaneous Gamma/Delta T-cell Lymphoma During Treatment with Etanercept for Rheumatoid Arthritis

Saved in:
Bibliographic Details
Published inActa dermato-venereologica Vol. 89; no. 6; pp. 653 - 654
Main Authors KOENS', Lianne, SENFF, Nancy J, VERMEER, Maarten H, KAREL RONDAY, H, WILLEMZE, Rein, JANSEN, Patty M
Format Journal Article
LanguageEnglish
Published Uppsala Acta dermato-venereologica 01.01.2009
Subjects
Aged
Antirheumatic Agents - administration & dosage
Antirheumatic Agents - adverse effects
Arthritis, Rheumatoid - drug therapy
Biological and medical sciences
Biopsy
Dermatology
Diseases of the osteoarticular system
Etanercept
Hematologic and hematopoietic diseases
Humans
Immunoglobulin G - administration & dosage
Immunoglobulin G - adverse effects
Inflammatory joint diseases
Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
Lymphoma, T-Cell, Cutaneous - chemically induced
Lymphoma, T-Cell, Cutaneous - pathology
Male
Medical sciences
Receptors, Tumor Necrosis Factor - administration & dosage
Skin - pathology
Skin Neoplasms - chemically induced
Skin Neoplasms - pathology
Tumor Necrosis Factor-alpha - antagonists & inhibitors
Immunopathology
Dermatology
Diseases of the osteoarticular system
Autoimmune disease
Malignant hemopathy
Inflammatory joint disease
Non Hodgkin lymphoma
Immunomodulator
Chronic
Treatment
Etanercept
Immunological investigation
Lymphoproliferative syndrome
Rheumatoid arthritis
T-Lymphocyte
Skin
Cancer
Online AccessGet full text

Cover

More Information
ISSN:0001-5555
1651-2057
DOI:10.2340/00015555-0728